Garchon H J, Djabiri F, Viard J P, Gajdos P, Bach J F
Institut National de la Santé et de la Recherche Médicale U25, Hôpital Necker, Paris, France.
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4668-72. doi: 10.1073/pnas.91.11.4668.
The muscle acetylcholine receptor is the major target of the autoimmune response in generalized myasthenia gravis. To investigate the role of the gene encoding the alpha subunit of the receptor (CHRNA), two stable polymorphic d[(GT).(CA)]dinucleotide repeats, designated HB and BB, were characterized within the first intron of CHRNA. The HB14 allele conferred a relative risk for myasthenia gravis of 2.5 in 81 unrelated patients compared with 100 control subjects. Very significantly, family analysis based on haplotype segregation data indicated that parental haplotypes associated with HB14 always segregated to the child with myasthenia gravis (P < 0.0002 for the comparison with the transmission of haplotypes not bearing HB*14), whereas their transmission to unaffected siblings was equilibrated. Myasthenia gravis patients also showed a high frequency of microsatellite variants unseen in controls. These findings implicate the CHRNA in susceptibility to myasthenia gravis.
肌肉乙酰胆碱受体是全身性重症肌无力自身免疫反应的主要靶点。为了研究编码该受体α亚基的基因(CHRNA)的作用,在CHRNA的第一个内含子中鉴定出两个稳定的多态性d[(GT).(CA)]二核苷酸重复序列,分别命名为HB和BB。与100名对照受试者相比,在81名无亲缘关系的患者中,HB14等位基因赋予重症肌无力的相对风险为2.5。非常显著的是,基于单倍型分离数据的家系分析表明,与HB14相关的亲代单倍型总是分离给患有重症肌无力的儿童(与未携带HB*14的单倍型传递相比,P < 0.0002),而它们向未受影响的兄弟姐妹的传递是平衡的。重症肌无力患者还表现出在对照中未见到的微卫星变异的高频率。这些发现表明CHRNA与重症肌无力易感性有关。